POU2AF1 Antikörper (AA 148-255)

Produktnummer ABIN7870757

Dieser Maus Monoklonal Antikörper detektiert spezifisch POU2AF1 in IHC (p). Es zeigt Reaktivität gegenüber Proben von Human.

Kurzübersicht für POU2AF1 Antikörper (AA 148-255) (ABIN7870757)

Target: POU2AF1 (POU Class 2 Associating Factor 1 (POU2AF1))

Reaktivität: Human

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Dieser POU2AF1 Antikörper ist unkonjugiert

Applikation: Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Güteklasse: Carrier-free

Klon: BOB1-7469

Produktdetails anti-POU2AF1 Antikörper

Bindungsspezifität: AA 148-255

Verwendungszweck: BOB-1 Antibody / POU2AF1 (azide and preservative free)

Aufreinigung: Protein A/G affinity

Immunogen: A recombinant partial protein (within amino acids 148-255) from the human protein was used as the immunogen for the BOB-1 antibody.

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: Optimal dilution of the BOB-1 antibody should be determined by the researcher.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1 mg/mL

Buffer: 1 mg/mL in 1X PBS, BSA free, sodium azide free

Konservierungsmittel: Azide free

Lagerung: -20 °C

Informationen zur Lagerung: Aliquot the BOB-1 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.

Details zu POU2AF1

Target: POU2AF1 (POU Class 2 Associating Factor 1 (POU2AF1))

Andere Bezeichnung: BOB-1

Hintergrund: BOB.1 expression in a variety of established B-cell lines, representing different stages of B-cell development, has suggested a constitutive, B-cell-specific expression pattern. LP cells in nodular lymphocyte predominant Hodgkin lymphoma, because they are germinal center-derived, are consistently immuno-positive for BOB.1. Conversely, only some cases of classical Hodgkin lymphoma show BOB.1 immuno-reactivity within the Hodgkin and Reed-Sternberg cells. Expression of BOB.1 has been reported in follicular center cell lymphoma, diffuse large B-cell lymphoma and some cases of acute myeloid leukemia. B-CLL, marginal zone lymphoma, and mantle cell lymphoma may show weak to moderate immunoreactivity.

UniProt: Q16633